CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Crespo Jessica CAO/SVP, Finance | Shares withheld for taxes | −1,913 | $1.25 | $2K | 161,478 |
| 2023-01-03 | Crespo Jessica CAO/SVP, Finance | Grant or award | +122,951 | 163,391 | ||
| 2023-01-03 | Crespo Jessica CAO/SVP, Finance | Grant or award · Option (Right to Buy) | +147,638 | 147,638 | ||
| 2022-03-18 | Crespo Jessica CAO/SVP, Finance | Grant or award | +22,940 | 40,440 | ||
| 2022-03-18 | Crespo Jessica CAO/SVP, Finance | Grant or award · Option (Right to Buy) | +84,192 | 84,192 |
Page 1 of 1 · 5 trades